This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2015-2019 France Therapeutic Drug Monitoring (TDM) Market: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
Summary This report presents data on the Sun Protection consumption trends in Austria. It analyzes Sun Protection consumption volumes and values at market and category level. It examines the components of change in the market for the historic (2008-2013) and forecast (2014-2018) years by volumes and values, as well as the manner ...
March 2015 | $200 | View Details >>
Summary Polyphor Ltd. (Polyphor) is a research-oriented pharmaceutical company. It discovers and develops macrocyclic drugs that address high unmet medical needs. The company’s product portfolio encompasses indications for the transplantation of hematopoietic stem cells especially in multiple myeloma patients; Pseudomonas infections; and protease inhibitor for chronic obstructive pulmonary disease, alpha-1-antitrypsin deficiency, ...
July 2015 | $250 | View Details >>
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015 Summary Global Markets Directs, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015, provides an overview of the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)s therapeutic pipeline. This report provides comprehensive information on the therapeutic ...
June 2015 | $2000 | View Details >>
This report presents data on the Toothbrushes & Replacement Heads consumption trends in Hong Kong. It analyzes Toothbrushes & Replacement Heads consumption volumes and values at market and category level in addition to brand share and distribution channel data. It examines the components of change in the market via study of ...
November 2012 | $200 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research